低酸血症:揭示了重症病患COVID-19患者的ICU死亡率与致命连接:一个多中心观察性研究
Şahin Temel1, Pervin Hanci2, Akbudak Ismail Hakkı3
1Erciyes University, School of Medicine, Department of Internal Medicine, Division of Intensive Care Medicine, Kayseri, Turkey.
Journal of medical biochemistry
|May 19, 2025
概括
低酸血症是重症COVID-19患者常见的疾病,与更糟糕的结果有关. 监测血清水平对于改善这些患者的护理和降低死亡率至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 腎科/泌尿科 腎科/泌尿科
背景情况:
- 低酸盐血症与各种患者群体的不良结果有关.
- 有限的数据存在于临界病的COVID-19患者的低酸血症的流行率和影响.
研究的目的:
- 为了确定COVID-19危急病患者中低酸血症的频率.
- 调查血清含量与临床结果之间的相关性.
主要方法:
- 对205名确诊COVID-19患者的RT-PCR进行了回顾性观察性研究.
- 包括患有呼吸衰竭的患者,需要接受ICU治疗>24小时.
- 分析了临床参数,并发症,呼吸辅助和血清水平.
主要成果:
- 25%的患者在ICU的前三天内出现了低血症 (的中位数为1.02 mmol/L).
- 低酸血症与显著更长的ICU停留有关 (p=0.046).
- 第三天水平独立预测了ICU死亡率 (HR=1.48,p=0.006).
结论:
- 低酸盐血症影响了严重病情严重的COVID-19患者的很大一部分.
- 这种情况与 ICU 死亡率的增加和 ICU 停留时间的延长有关.
- 对于重症COVID-19患者,建议定期监测血清的水平.
相关概念视频
01:28Pneumonia IV: Management
280
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
280
01:30Pneumonia III: Complications and Assessment
135
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
135